Biotech Stocks

William Blair Maintains Outperform On BioDelivery Sciences

William Blair today maintained an Outperform rating on BioDelivery Sciences (BDSI) with $23.00 price target, which is derived through a net present value analysis …

William Blair Reiterates Outperform Rating For Dynavax

In a research note released this morning, William Blair reiterated coverage on Dynavax Technologies Corporation (DVAX) with an Outperform rating and a price target of …

OraSure Technologies Price Target Raised at Canaccord Following Agreement With AbbVie

In a research note issued today, Canaccord analyst Mark Massaro reiterated a Buy rating and boosted his price target on OraSure Technologies (OSUR) to $11.00 …

Valeant Pharmaceuticals Reiterated With A Buy At Canaccord

In a research note issued today, Canaccord maintained coverage with a “Buy” rating on Valeant Pharmaceuticals (VRX), and a price target of $168.00 a share.

Roth Capital Sees Downside in Dendreon Corporation Shares

In a research note issued today, Roth Capital reiterated coverage with a “Sell” rating on Dendreon Corporation (DNDN) and lowered its price target to $0.50 from …

Maxim Group Assumes Advanced Cell Technology at Buy

In a research note released today, Maxim Group assumed coverage on Advanced Cell Technology, Inc. (ACTC) with a Buy rating and a price …

Roth Capital Reaffirms EnteroMedics at Buy; Positive Bias Heading Into The FDA Panel

In a research note issued today, Roth Capital reiterated coverage with a “Buy” rating on EnteroMedics Inc. (ETRM), and a price target of $3.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts